Electroceuticals Industry Landscape
Rajesh Ramanujam, Saurabh Chopra, Rainer Unterguggenberger, Xumin Wu
October 14, 2022
Abstract
Electroceuticals is a term that refers to Electronic Pharmaceuticals. This field is also called Bioelectronic Medicine. The term is used for tiny electronic devices that are programmed to read and modify electrical signals passing along nerves. Their goal is to restore health. The first and most well known application is the pacemaker invented in 1958. Since then several other Electroceuticals have been FDA approved:
- Cyberonic System – Controlling epileptic seizures (approved 1997)
- Cyberonic System – treat depression (approved 2005)
- Medtronic InterStim System – urinary incontinence (approved 2011)
- Maestro – treat obesity (approved 2015)
Electroceuticals established before 2015 share one major drawback, their selectivity. The Side effects from non-selective stimulation, limits treatment options to only ⅓ of patients (pileptic seizures).
Recently there has been substantial investments made to address these issues. In this report we want to highlight two companies that we feel will have technical relevance in the near future.